5-aminolevulinic acid-photodynamic therapy is a potential approach for kerion

[1]  G. Fabbrocini,et al.  New Applications of Photodynamic Therapy in the Management of Candidiasis. , 2021, Journal of fungi.

[2]  B. Dong,et al.  Aetiology of tinea capitis in China: a multicentre prospective study * , 2021, The British journal of dermatology.

[3]  C. Aspíroz,et al.  Tinea capitis caused by Microsporum canis treated with methyl‐aminolevulinate daylight photodynamic therapy and ketoconazole shampooing , 2021, Photodermatology, photoimmunology & photomedicine.

[4]  G. Girolomoni,et al.  A case of kerion celsi caused by Trichophyton tonsurans , 2020, Pediatrics International.

[5]  G. Jemec,et al.  Photodynamic therapy treatment of superficial fungal infections: a systematic review. , 2020, Photodiagnosis and photodynamic therapy.

[6]  Hong-Wei Wang,et al.  Successful photodynamic therapy in treating tinea capitis child with liver dysfunction caused by oral antifungal drugs: A case report. , 2020, Photodiagnosis and Photodynamic Therapy.

[7]  A. Leung,et al.  Tinea Capitis: An Updated Review. , 2020, Recent patents on inflammation & allergy drug discovery.

[8]  Weiwei Wu,et al.  Successful treatment of kerion with itraconazole and ALA-PDT: A case report. , 2019, Photodiagnosis and photodynamic therapy.

[9]  R. Mays,et al.  Tinea capitis in children: a systematic review of management , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  A. John,et al.  The kerion: an angry tinea capitis , 2018, International journal of dermatology.

[11]  You-Kun Lin,et al.  Photodynamic therapy as an antifungal treatment. , 2016, Experimental and therapeutic medicine.

[12]  M. Gold,et al.  Photodynamic Therapy: A Clinical Consensus Guide , 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[13]  J. Zhu,et al.  Successful treatment of severe kerion Celsi in an immunocompromised girl with evacuation of pus, terbinafine and short course glucocorticosteroids. , 2016, Journal de mycologie medicale.

[14]  L. C. Fuller,et al.  British Association of Dermatologists' guidelines for the management of tinea capitis 2014 , 2014, The British journal of dermatology.

[15]  C. Gouveia,et al.  Remember kerion celsi , 2013, BMJ Case Reports.

[16]  M. Mokni,et al.  Inflammatory Tinea capitis: a 12‐year study and a review of the literature , 2013, Mycoses.

[17]  R. Schwartz,et al.  Tinea capitis: still an unsolved problem? , 2011, Mycoses.

[18]  R. Grimalt,et al.  Management of tinea capitis in childhood , 2010, Clinical, cosmetic and investigational dermatology.

[19]  T. Kakourou,et al.  Guidelines for the Management of Tinea Capitis in Children , 2010, Pediatric dermatology.

[20]  P. McCarron,et al.  Antifungal photodynamic therapy. , 2008, Microbiological research.

[21]  D. Soll,et al.  Clade-related amphotericin B resistance among South African Candida albicans isolates. , 2005, Diagnostic microbiology and infectious disease.

[22]  P. Calzavara-Pinton,et al.  Photodynamic therapy of interdigital mycoses of the feet with topical application of 5‐aminolevulinic acid , 2004, Photodermatology, photoimmunology & photomedicine.

[23]  D. Soll,et al.  Clade-Specific Flucytosine Resistance Is Due to a Single Nucleotide Change in the FUR1 Gene of Candida albicans , 2004, Antimicrobial Agents and Chemotherapy.

[24]  D. Soll,et al.  Flucytosine Resistance Is Restricted to a Single Genetic Clade of Candida albicans , 2004, Antimicrobial Agents and Chemotherapy.

[25]  J. Blumer,et al.  Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study. , 2002, Pediatrics.

[26]  C. Romano,et al.  Tinea Capitis in Infants Less Than 1 Year of Age , 2001, Pediatric dermatology.

[27]  M. Ghannoum,et al.  New targets and delivery systems for antifungal therapy. , 2000, Medical mycology.